Sales & Marketing News | pharmaphorum

News

In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO.

News

There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer.

News

Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he first said it would be.

News

DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.

News

The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.

News

The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.